Uflex Ltd (UFLEX) Q2FY26 Concall Summary - Sep-2025 Qtr
Performance Overview
- The company reported a decent performance in H1 FY26, navigating headwinds such as tariffs, GST transition impacts, and an extended monsoon, which led to a flat quarter in terms of revenue and EBITDA.
- On a half-yearly basis (H1 FY26 vs H1 FY25), sales grew by 3%, and EBITDA increased by 4%, with PAT showing a significant 150% rise, primarily due to the impact of currency translation losses in the prior year period.
- The aseptic packaging unit achieved its highest-ever H1 volume, recording a 5.5% year-over-year growth, with a newly expanded capacity of 12 billion packs per year expected to yield results from January onwards.
- The company is facing challenges from a significant increase in BOPET and BOPP film imports into India, which are up 120% and 100% YoY in H1 respectively, impacting domestic pricing and volumes.
- Strategic growth projects are advancing, including a new BOPP facility in Dharwad, a PET recycling plant in Noida, and aseptic packaging and WPP facilities in Egypt and Mexico, which are expected to add approximately INR 3,000 crores in revenue at optimal capacity.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.